Data from two new coronavirus vaccine tests have revealed that they are less effective in protecting humans from the new South African variant. Tests from the Novavax and Johnson & Johnson vaccines have shown that their vaccines are less effective. The Novavax test showed efficacy at 50 percent, Johnson & Johnson reported one view of the vaccine at 66 percent.
According to reports by the Guardian, Dr. Dan Barouch, a researcher at Beth Israel Deaconess medical center in Boston, who helped with the Johnson & Johnson vaccine, said the new variant means a different pandemic. here you are. Also, the Serum Institute of India (SII) has now obtained the approval of the Drug Administrator to find the bridge check for Novavax COVID-19 vaccine candidate in India. The pharmaceutical company has applied for Novavax vaccine candidate approval, just days after the American company released data of their UK test, showing that the vaccine had an 89 percent efficacy.
Read: New COVID-19 variety discovered in South Africa: Everything you need to know about
The Novavax COVID vaccine candidate, named – NVX-CoV2373 – is a protein-based vaccine, which is now being tested by the General Administration of Drugs of India (DCGI) for testing. The Serum Institute, which already mass-produces Covishield – developed by Oxford-AstraZeneca – in India, plans to start mass production of the Novavax vaccine from April. The Indian pharmaceutical company has also received funding from GAVI – The Vaccine Alliance – for pre-production and collection of the endangered vaccine candidate, similar to the way it did with it. the Oxford-AstraZeneca vaccine in India.
Various South Africans
In late December, another version of the existing genome of the coronavirus was discovered in South Africa, the health ministry announced last week. As reported, the new variant 501.V2 in South Africa is also linked to the fast transmission speed of the second wave which is also affecting younger patients. South African Health Minister Zwelini Mkhize also said the new strain has been reported to the World Health Organization (WHO).
Read: COVID vaccines made in India reach Oman; Emerging ‘Friendship spans Millennia’
Even though pathogens are constantly evolving and it is also a well-known fact among scientists, the variant that is spreading in Britain is currently known as VUI-202012/01 on proved to be 70 percent more infectious than the current version. So he has raised fears about overcoming the conventional virus that is already on the world’s rock. However, the new variation in South Africa is also causing a reported shift in the country’s epidemiological landscape.
Read: ‘Call Wake Up’: Fauci Expressed Over COVID Shots’ Reduced Anti-Virus Results
Also read: Mumbai ‘s COVID-19 Active Tally rises to 5567; Patient doubling rate rate at 556 days